135 related articles for article (PubMed ID: 2178931)
21. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin (MK 733): an effective treatment for hypercholesterolemia.
Lintott CJ; Scott RS; Nye ER; Robertson MC; Sutherland WH
Aust N Z J Med; 1989 Aug; 19(4):317-20. PubMed ID: 2675812
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
Darioli R; Bovet P; Brunner HR; Bercher L
Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221
[TBL] [Abstract][Full Text] [Related]
24. Long-term experience (6 years) with simvastatin in patients with heterozygous familial hypercholesterolaemia.
Knops RE; Kroon AA; Mol MJ; Stuyt PM; Stalenhoef AF
Neth J Med; 1995 Apr; 46(4):171-8. PubMed ID: 7760966
[TBL] [Abstract][Full Text] [Related]
25. Combination drug therapy with HMG CoA reductase inhibitors and bile acid sequestrants for hypercholesterolemia.
Erkelens DW
Cardiology; 1990; 77 Suppl 4():33-8. PubMed ID: 2073670
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
Lewis-Barned NJ; Ball MJ
N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661
[TBL] [Abstract][Full Text] [Related]
27. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
28. Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia.
Weisweiler P
Eur J Clin Pharmacol; 1988; 35(6):579-83. PubMed ID: 3234467
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
Mol MJ; Stuyt PM; Stalenhoef AF
Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
[TBL] [Abstract][Full Text] [Related]
30. [Simvastatin in the treatment of hypercholesterolemia].
Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
[TBL] [Abstract][Full Text] [Related]
31. Improvement in arterial stiffness during hypolipidaemic therapy is offset by weight gain.
Matthews PG; Wahlqvist ML; Marks SJ; Myers KA; Hodgson JM
Int J Obes Relat Metab Disord; 1993 Oct; 17(10):579-83. PubMed ID: 8242126
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
33. [Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
Martens LL; Rutten FF; Kuijpens JL; Winter J
Ned Tijdschr Geneeskd; 1991 Apr; 135(15):655-9. PubMed ID: 1903849
[TBL] [Abstract][Full Text] [Related]
34. [Effects of simvastatin on atherogenic blood lipid pattern].
Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
[TBL] [Abstract][Full Text] [Related]
35. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
Maher VM; Thompson GR
Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
[TBL] [Abstract][Full Text] [Related]
36. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels.
Wiklund O; Angelin B; Fager G; Eriksson M; Olofsson SO; Berglund L; Lindén T; Sjöberg A; Bondjers G
J Intern Med; 1990 Sep; 228(3):241-7. PubMed ID: 2119417
[TBL] [Abstract][Full Text] [Related]
37. Effects of ketoconazole on plasma lipids and lipoprotein(a) in familial hypercholesterolaemia, compared with simvastatin.
Stalenhoef AF; Stuyt PM; de Graaf J
Neth J Med; 1997 Jul; 51(1):10-5. PubMed ID: 9260485
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramine.
Martens LL; Rutten FF; Erkelens DW; Ascoop CA
Am J Med; 1989 Oct; 87(4A):54S-58S. PubMed ID: 2508473
[TBL] [Abstract][Full Text] [Related]
39. Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol.
Desager JP; Horsmans Y; Harvengt C
J Clin Pharmacol; 1991 Jun; 31(6):537-42. PubMed ID: 1880219
[TBL] [Abstract][Full Text] [Related]
40. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
